Differential effects of immunisation with mycobacterial 65 kD heat shock protein on two models of autoimmunity.
The effects of preimmunisation with the 65 kD mycobacterial heat shock protein (hsp65) on 2 murine models of autoimmunity were compared. Experimental autoimmune haemolytic anaemia (AIHA) can be provoked in mice by repeated injection with rat red blood cells (RBC). In this model, preimmunisation with hsp65 10 days before induction of disease resulted in a partial, but significant, reduction in RBC-bound autoantibody levels measured by Coombs' test. However, preimmunisation with human IgG (hIgG) was associated with a similar suppressive effect. Administration of neither hsp65 nor hIgG affected the direct or indirect anti-rat agglutinin titres of mice subsequently injected with rat RBC. Injection of hsp65 or hIgG prior to induction of AIHA elicited the production of IgG antibodies against the respective immunogen, as judged by enzyme-linked immunosorbent assays. In contrast to the results in experimental AIHA, pristane-induced arthritis (PIA) was effectively prevented by preimmunisation with hsp65, but not with hIgG. It is considered that, whilst hsp65 injection may slightly reduce subsequent anti-RBC autoantibody production in AIHA by antigenic competition, such a mechanism cannot account for the substantial protection against PIA afforded by hsp65 preimmunisation. We suggest that the high, sustained production of anti-hsp65 antibodies observed in mice given hsp65 and pristane may play a role in specifically suppressing arthritogenic immune responses in PIA.
Barker
R N
RN
Department of Pathology and Microbiology, University of Bristol, UK.
Webb
G R
GR
Thompson
S J
SJ
Ghoraishian
M
M
Ponsford
F M
FM
Elson
C J
CJ
D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D001323:Autoantibodies / Q000097:blood; D015551:Autoimmunity; D001426:Bacterial Proteins; D018834:Chaperonin 60; D018833:Chaperonins; D004912:Erythrocytes / Q000276:immunology; D006360:Heat-Shock Proteins / Q000276:immunology*; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000008:administration & dosage; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D008954:Models, Biological; D009161:Mycobacterium / Q000276:immunology; D051381:Rats; D013729:Terpenes
D001323:Autoantibodies; D001426:Bacterial Proteins; D018834:Chaperonin 60; D006360:Heat-Shock Proteins; D007074:Immunoglobulin G; D013729:Terpenes; C074119:heat-shock protein 65, Mycobacterium; C009042:pristane; D018833:Chaperonins